Lead exposure and tremor among older men: the VA normative aging study
- PMID: 25633720
- PMCID: PMC4421770
- DOI: 10.1289/ehp.1408535
Lead exposure and tremor among older men: the VA normative aging study
Abstract
Background: Tremor is one of the most common neurological signs, yet its etiology is poorly understood. Case-control studies suggest an association between blood lead and essential tremor, and that this association is modified by polymorphisms in the δ-aminolevulinic acid dehydrogenase (ALAD) gene.
Objective: We aimed to examine the relationship between lead and tremor, including modification by ALAD, in a prospective cohort study, using both blood lead and bone lead-a biomarker of cumulative lead exposure.
Methods: We measured tibia (n = 670) and patella (n = 672) bone lead and blood lead (n = 807) among older men (age range, 50-98 years) in the VA Normative Aging Study cohort. A tremor score was created based on an approach using hand-drawing samples. ALAD genotype was dichotomized as ALAD-2 carriers or not. We used linear regression adjusted for age, education, smoking, and alcohol intake to estimate the associations between lead biomarkers and tremor score.
Results: In unadjusted analyses, there was a marginal association between quintiles of all lead biomarkers and tremor scores (p-values < 0.13), which did not persist in adjusted models. Age was the strongest predictor of tremor. Among those younger than the median age (68.9 years), tremor increased significantly with blood lead (p = 0.03), but this pattern was not apparent for bone lead. We did not see modification by ALAD or an association between bone lead and change in tremor score over time.
Conclusion: Our results do not strongly support an association between lead exposure and tremor, and suggest no association with cumulative lead biomarkers, although there is some suggestion that blood lead may be associated with tremor among the younger men in our cohort.
Conflict of interest statement
The contents of this paper are solely the responsibility of the authors. The views expressed in this paper do not necessarily represent the views of the VA.
The authors declare they have no actual or potential competing financial interests.
References
-
- Alonso A, Logroscino G, Hernán MA. Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2010;81(11):1249–1252. - PubMed
-
- Alonso A, Mosley TH, Jr, Gottesman RF, Catellier D, Sharrett AR, Coresh J. Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study. J Neurol Neurosurg Psychiatry. 2009;80(11):1194–1201. - PMC - PubMed
-
- Bell B, Rose CL, Damon A. The Veterans Administration longitudinal study of healthy aging. Gerontologist. 1966;6(4):179–184. - PubMed
-
- Bradley WG, Mash DC. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler. 2009;10(suppl 2):7–20. - PubMed
-
- Caller TA, Field NC, Chipman JW, Shi X, Harris BT, Stommel EW. Spatial clustering of amyotrophic lateral sclerosis and the potential role of BMAA. Amyotroph Lateral Scler. 2012;13(1):25–32. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01-AA08941/AA/NIAAA NIH HHS/United States
- R01 AG018436/AG/NIA NIH HHS/United States
- P30 ES000002/ES/NIEHS NIH HHS/United States
- T42OH008416/ACL/ACL HHS/United States
- P42 ES005947/ES/NIEHS NIH HHS/United States
- 5-P42-ES05947/ES/NIEHS NIH HHS/United States
- R01 ES005257/ES/NIEHS NIH HHS/United States
- R01 AG014345/AG/NIA NIH HHS/United States
- R01-AG18436/AG/NIA NIH HHS/United States
- R01-ES05257/ES/NIEHS NIH HHS/United States
- T42/OH008416/OH/NIOSH CDC HHS/United States
- R01 AG013006/AG/NIA NIH HHS/United States
- T42 OH008416/OH/NIOSH CDC HHS/United States
- ES-00002/ES/NIEHS NIH HHS/United States
- R01-AG14345/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
